Podcast 588 – “Good News on the Psychedelic Front” – Pt. 2

Support Lorenzo on Patreon.com Guest speaker: Rick Doblin PROGRAM NOTES: Date this lecture was recorded: August 31, 2018.] Today we continue with the second part of the 2018 Palenque Norte Lecture given by Rick Doblin, the president of the Multidisciplinary Association for Psychedelic Studies. In addition to learning some new information about the current state of MDMA research, Rick ends the Q&A session with some information about mescaline that I'd never heard before. As he says, "Mescaline is the most important psychedelic that isn't being researched." Also, there is an announcement about a screening of the film "From Shock To Awe" that was discussed here in the salon three years ago when the producers were first raising the funding for the project. It has now been completed and will be screened in select theaters on November 12, 2018. Full details are at the beginning of today's program. [NOTE: The following quotations are by Rick Doblin.] "We got an agreement letter on July 28th, and what it means is that the FDA is legally bound to approve MDMA if we get statistically significant evidence of efficacy from this design and no new safety problems come up." "Mescaline is the most important psychedelic that isn't being researched." Download MP3 PCs – Right click, select option Macs – Ctrl-Click, select option From Shock To Awe Download a free copy of Lorenzo's latest book The Chronicles of Lorenzo - Volume 1

Om Podcasten

Since 2005, Lorenzo Hagerty has been podcasting interviews and talks concerning the use and benefits of psychoactive plants and chemicals, both in their natural settings and in medical research institutions. Past speakers include Sasha Shulgin, Annie Oak, Rick Doblin, Daniel Pinchbeck, Shonagh Home, Bruce Damer, Aldous Huxley and others. And there have been over 200 programs featuring talks by Terence McKenna. Also interviews with several of the now long gone elders, such as Gary Fisher, Myron Stolaroff, and Al Hubbard have also been featured.